Homocysteine and the B-Vitamin Connection to Vascular Aging

Homocysteine is an amino acid byproduct of protein metabolism, and elevated levels in the blood have been associated with damage to the lining of blood vessels, increased clotting tendency, and higher cardiovascular risk in multiple observational studies. Unlike many biomarkers, homocysteine has a fairly well-understood nutritional lever attached to it: B vitamins, particularly B6, B12, and folate, are required cofactors for the enzymes that clear homocysteine from the blood.

Deficiencies in these B vitamins, whether from diet, absorption issues, or certain genetic variants affecting the MTHFR enzyme, can cause homocysteine to accumulate. Clinical trials testing whether B-vitamin supplementation to lower homocysteine actually reduces cardiovascular events have produced mixed results, which has led researchers to view elevated homocysteine as a useful marker of vascular risk and nutrient status, even while the direct causal role in disease remains debated.

Why this matters for tracking: homocysteine testing is one of the more actionable biomarkers available, since an elevated result points fairly directly toward specific B-vitamin status worth investigating further.